Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid Inhalation for Emphysema in AATD
NCT03114020Phase 2Completed
- Start
- Mar 2017
- Primary completion
- Nov 2019
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in emphysema comparing Hyaluronic Acid with Placebo (2 arms). Primary endpoints: Sputum, plasma and urine concentrations of desmosine and isodesmosine at 28 days and Assessment of pulmonary function tests at 28 days. Started Mar 2017; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT03114020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03114020.